THE EFFICACY AND SAFETY OF CANGRELOR WITH AND WITHOUT GLYCOPROTEIN IIB/IIIA INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A POOLED ANALYSIS OF THE CHAMPION TRIALS.

Authors :: Vaduganathan, Muthiah
Harrington, Robert
Stone, Gregg
Steg, Philippe
Gibson, C. Michael
Hamm, Christian
Price, Matthew
Menozzi, Alberto
Prats, Jayne
Deliargyris, Efthymios
Mahaffey, Kenneth
White, Harvey
Bhatt, Deepak
Source :: Journal of the American College of Cardiology (JACC). Apr2016 Supplement, Vol. 67 Issue 13S, p452-452. 1p.
Publication Year :: 2016

Subjects :: *PERCUTANEOUS coronary intervention
*CARDIOVASCULAR diseases
*PATIENTS
*PLATELET aggregation inhibitors
*GLYCOPROTEINS
*DRUG efficacy
*MEDICATION safety
*CLINICAL trials
*THERAPEUTICS

Full Text Access

Tools